An interventional study of 5A's/5R's advice and Brief leaflet on health warning and smoking cessation in Smoking Cessation and Mobile Health, sponsored by Beijing Normal University. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-20.
Sponsored by Beijing Normal University · Not applicable, Interventional, and Treatment
This study aims to explore the feasibility, preliminary effectiveness, and implementation outcomes of chatbot-led smoking cessation support in community smokers.
350 studies on the registry are indexed under Smoking Cessation; 145 are open to participants now.
This study's planned enrollment of 150 is close to the median of 150 across 326 interventional studies indexed under Smoking Cessation.
Browse Smoking Cessation studies →Beijing Normal University is the lead sponsor of 31 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
5A's/5R's advice+ Chatbot-led group support+ Counselor-led individual support+ health warning leaflet+ Self-help booklet
Behavioral: 5A's/5R's advice · Other: Brief leaflet on health warning and smoking cessation · Other: Self-help smoking cessation booklet · Behavioral: Counselor-led individual support · Behavioral: Chatbot-led group support
5A's/5R's advice+ Chatbot-led group support+ health warning leaflet+ Self-help booklet
Behavioral: 5A's/5R's advice · Other: Brief leaflet on health warning and smoking cessation · Other: Self-help smoking cessation booklet · Behavioral: Chatbot-led group support
5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.
The contents of the leaflet include the absolute risk of smoking, diseases caused by active and second-hand smoking, horrible pictorial warnings of the health consequences of active and second-hand smoking, and the benefits of quitting.
The contents include information about the benefits of quitting, methods to quit, how to handle withdrawal symptoms, misperceptions of quitting, etc.
Participants will receive three months of counselor-led individual support via WeChat. The regular messages and instant messaging on psychosocial support aim to provide cessation advice, increase self-efficacy and confidence, and social support and behavioral capacity of quitting.
Participants will receive three months of chatbot-led group support via WeChat.
Participation rate of eligible smokers
the percentage of eligible smokers out of the total number of smokers screened
Time frame: Baseline
Biochemical validated quit rate at 6 months follow-up
The primary outcomes are biochemically validated quit rate (exhaled CO \< 4 ppm or salivary cotinine \< 30 ng/ml)
Time frame: 6 months follow-up
Biochemical validated quit rate at 3 months follow-up
The primary outcomes are biochemically validated quit rate (exhaled CO \< 4 ppm or salivary cotinine \< 30 ng/ml) at 3-month in the two groups
Time frame: 3 months follow-up
Self-reported 7-day point prevalence quit rate
Self-reported 7-day point prevalence quit rate in the two groups
Time frame: 3 and 6 months follow-up
Smoking reduction rate
Rate of smoking reduction by at least half of baseline amount in the two groups
Time frame: 3 and 6 months follow-up
Engagement in chatbot-led group support and/or counselor-led individual support
Self-reported engagement in chatbot-led/counselor-led support in the two groups
Time frame: 3 and 6 months follow-up
Plan to share: No
This study is status unknown, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beijing Normal University